Anjali Sharathkumar

Dabigatran etexilate for the treatment of acute venous thromboembolism in children (DIVERSITY): a randomised, controlled, open-label, phase 2b/3, non-inferiority trial

Leonardo R. Brandão, Matteo Luciani, Lisa Bomgaars et al. · The Lancet Haematology · 2020 · 149 citations · Full text

Medicine, Pediatrics, Pharmacotherapy +12

Effect of Anticoagulant Therapy for 6 Weeks vs 3 Months on Recurrence and Bleeding Events in Patients Younger Than 21 Years of Age With Provoked Venous Thromboembolism

Neil A. Goldenberg, John M. Kittelson, Thomas C. Abshire et al. · JAMA · 2022 · 94 citations · Full text

Medicine, Hematology, Internal Medicine +17

Risk‐prediction tool for identifying hospitalized children with a predisposition for development of venous thromboembolism: Peds‐Clot clinical Decision Rule

Anjali Sharathkumar, Arash Mahajerin, L. HEIDT et al. · Journal of Thrombosis and Haemostasis · 2012 · 81 citations · Full text

Medicine, Child Health, Pediatrics +17

Natural history of arterial and venous thrombosis in children treated with low molecular weight heparin: a longitudinal study by ultrasound

Shoshana Revel‐Vilk, Anjali Sharathkumar, Patricia Massicotte et al. · Journal of Thrombosis and Haemostasis · 2004 · 74 citations · Full text

Medicine, Child Health, Pediatrics +16

Prevalence and risk factors of cardiovascular disease (CVD) events among patients with haemophilia: experience of a single haemophilia treatment centre in the United States (US)

Anjali Sharathkumar, J. Michael Soucie, Brandy Trawinski et al. · Haemophilia · 2011 · 74 citations

Public Health, Preventive Medicine, Clinical Epidemiology +15